Cargando…
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Hepatocellular carcinoma is one of the most common malignancies and has a poor prognosis. The ubiquitin-proteasome pathway is required for the degradation of most short-lived proteins. CMTM6 has been implicated in the progression of various tumors, but its biological function and the underlying mole...
Autores principales: | Huang, Yue, Zhu, Yingqin, Yang, Jieying, Pan, Qiuzhong, Zhao, Jingjing, Song, Mengjia, Yang, Chaopin, Han, Yulong, Tang, Yan, Wang, Qijing, He, Jia, Li, Yongqiang, He, Junyi, Chen, Hao, Weng, Desheng, Xiang, Tong, Xia, Jian Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933468/ https://www.ncbi.nlm.nih.gov/pubmed/35304440 http://dx.doi.org/10.1038/s41419-022-04676-1 |
Ejemplares similares
-
SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway
por: Yang, Jieying, et al.
Publicado: (2022) -
Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma
por: Yang, Jieying, et al.
Publicado: (2023) -
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin
por: Sun, Fengze, et al.
Publicado: (2021) -
Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma
por: Song, Mengjia, et al.
Publicado: (2019) -
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
por: Song, Mengjia, et al.
Publicado: (2020)